am 580 and dactinomycin
am 580 has been researched along with dactinomycin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, Q; Ross, AC | 1 |
Other Studies
1 other study(ies) available for am 580 and dactinomycin
| Article | Year |
|---|---|
Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
Topics: Animals; Antigen Presentation; Antigens, CD1; Antigens, CD1d; Antineoplastic Agents; Benzoates; Cell Proliferation; Dactinomycin; Galactosylceramides; Gene Expression Regulation; Glycolipids; HL-60 Cells; Humans; Killer Cells, Natural; Lymphocyte Activation; Macrophages, Peritoneal; Male; Mice; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Response Elements; Retinoic Acid Receptor alpha; RNA, Messenger; Spleen; T-Lymphocytes; Tetrahydronaphthalenes; Transcription, Genetic; Tretinoin; U937 Cells | 2007 |